Prospective Evidence of Concomitant Pancreatic Ductal Adenocarcinoma Risk Among Patients With Branch-duct Intraductal Papillary Mucinous Neoplasms Without Worrisome Features/High-risk Stigmata at Baseline

OBJECTIVE: To evaluate the natural history, especially concomitant pancreatic ductal adenocarcinoma (cPDAC) risk in patients with branch-duct intraductal papillary mucinous neoplasm (BD-IPMN) without worrisome features (WF) or high-risk stigmata (HRS). SUMMARY BACKGROUND DATA: BD-IPMNs without WF/HRS are considered low-risk, yet optimal surveillance strategies remain uncertain. METHODS: In a prospective multicenter Japan Pancreas Society registry, 1234 patients with BD-IPMN without WF/HRS underwent imaging and laboratory surveillance every 6 months for up to 5.17 years. Cumulative incidence, standardized incidence ratios (SIRs), and competing-risk analyses were performed to assess advanced pancreatic neoplasia, defined as IPMN high-grade dysplasia (IPMN-HGD), invasive IPMN, or cPDAC, and associated risk factors. Outcomes were also evaluated under simulated guideline-recommended extended surveillance intervals. RESULTS: During 5.17 years of follow-up, advanced pancreatic neoplasia developed in 26 patients: 10 IPMN-HGD/invasive IPMN and 16 cPDAC. The 5.17-year cumulative incidence was 2.48%; SIRs relative to the general population were 8.01 overall, 3.07 for IPMN-HGD/invasive IPMN, and 4.91 for cPDAC. The cPDAC SIRs were 6.21 and 3.02 for cysts <20 mm and ≥20 mm, respectively. Diabetes history and mural nodule development predicted IPMN-HGD/invasive IPMN, whereas CA19-9 elevation and new or worsening diabetes predicted cPDAC. Of 19 patients eligible for surveillance interval extension, 13 (68%) had a later simulated detection date. CONCLUSION: Patients with BD-IPMN without WF/HRS at baseline had 3.07 and 4.91 times the incidences of IPMN-HGD/invasive IPMN and cPDAC expected in the general population, respectively. Surveillance based solely on cyst stability may warrant caution regarding the timely detection of surgically resectable pancreatic cancer.

Authors

Institutions

Publication Details

Journal
Annals of Surgery
Published
2026-11-17
DOI
https://doi.org/10.1097/sla.0000000000007255
Primary Topic
Pancreatic and Hepatic Oncology Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Prospective Evidence of Concomitant Pancreatic Ductal Adenocarcinoma Risk Among Patients With Branch-duct Intraductal Papillary Mucinous Neoplasms Without Worrisome Features/High-risk Stigmata at Baseline

Nobuhiko Fukuba, Shingo Kozono, Teppei Yoshioka, Hiroyuki Uehara et al.
3 links
Annals of Surgery
Pancreatic and Hepatic Oncology Research
article

Prospective Evidence of Concomitant Pancreatic Ductal Adenocarcinoma Risk Among Patients With Branch-duct Intraductal Papillary Mucinous Neoplasms Without Worrisome Features/High-risk Stigmata at Baseline

Nobuhiko Fukuba, Shingo Kozono, Teppei Yoshioka, Hiroyuki Uehara, Teru Kumagi, Shinichi Takano, Daisuke Yamada, Hiroshi Ohyama, Makoto Abue, Reiko E. Yamada, Shinichi Hashimoto, Hiroki Oyama, Masaki Kuwatani, Nao Fujimori, Toru Maruo, Toshifumi Kin, Noboru Ideno, Yoshihiro Nishikawa, Koji Yamakoshi, Hiroya Terabe, Shinsuke Koshita, Nobuo Toda, Yoshio Sogame, Keiji Hanada, Toyoma Kaku, Hiroyuki Maguchi, Fuyuhiko Motoi, Atsushi Masamune, Kazuo Hara, Toshiyasu Shiratori, Yousuke Nakai, Tsukasa Ikeura, Motohiro Yoshinari, Tetsuya Takikawa, Mamoru Takenaka, Takao Ohtsuka, Kasen Kobashikawa, Takahiro Anami, Yoshifumi Fujimoto, Yasutaka Ishii, Akitoshi Kobayashi, Yoshinari Furukawa, Manabu Kawai, Shinya Uemura, Satoshi Tanno, Yasuhisa Mori, Kentaro Sudo, Junya Gibo, Kosuke Okuwaki, Yukiko Ito, Masafumi Nakamura, Masao Tanaka, Shoji Tokunaga, Kazuyuki Matsumoto
article en

Abstract

OBJECTIVE: To evaluate the natural history, especially concomitant pancreatic ductal adenocarcinoma (cPDAC) risk in patients with branch-duct intraductal papillary mucinous neoplasm (BD-IPMN) without worrisome features (WF) or high-risk stigmata (HRS). SUMMARY BACKGROUND DATA: BD-IPMNs without WF/HRS are considered low-risk, yet optimal surveillance strategies remain uncertain. METHODS: In a prospective multicenter Japan Pancreas Society registry, 1234 patients with BD-IPMN without WF/HRS underwent imaging and laboratory surveillance every 6 months for up to 5.17 years. Cumulative incidence, standardized incidence ratios (SIRs), and competing-risk analyses were performed to assess advanced pancreatic neoplasia, defined as IPMN high-grade dysplasia (IPMN-HGD), invasive IPMN, or cPDAC, and associated risk factors. Outcomes were also evaluated under simulated guideline-recommended extended surveillance intervals. RESULTS: During 5.17 years of follow-up, advanced pancreatic neoplasia developed in 26 patients: 10 IPMN-HGD/invasive IPMN and 16 cPDAC. The 5.17-year cumulative incidence was 2.48%; SIRs relative to the general population were 8.01 overall, 3.07 for IPMN-HGD/invasive IPMN, and 4.91 for cPDAC. The cPDAC SIRs were 6.21 and 3.02 for cysts <20 mm and ≥20 mm, respectively. Diabetes history and mural nodule development predicted IPMN-HGD/invasive IPMN, whereas CA19-9 elevation and new or worsening diabetes predicted cPDAC. Of 19 patients eligible for surveillance interval extension, 13 (68%) had a later simulated detection date. CONCLUSION: Patients with BD-IPMN without WF/HRS at baseline had 3.07 and 4.91 times the incidences of IPMN-HGD/invasive IPMN and cPDAC expected in the general population, respectively. Surveillance based solely on cyst stability may warrant caution regarding the timely detection of surgically resectable pancreatic cancer.

Annals of Surgery
Kurume University (JP), Kagoshima University (JP), Yamagata University (JP), Hiroshima University (JP), Kansai Medical University (JP), Kyushu University (JP), Chiba University (JP), Shimane University (JP), University of Occupational and Environmental Health Japan (JP), Wakayama Medical University (JP), Tohoku University (JP), Kyoto University (JP), National Kyushu Medical Center (JP), Fukuoka University (JP), Kyoto Prefectural University of Medicine (JP), Kurume University Hospital (JP), Okayama University Hospital (JP), Hiroshima General Hospital (JP), Japanese Red Cross Medical Center (JP), Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital (JP), Gifu University Hospital (JP), Miyagi Prefectural Hospital Organization (JP), Yodogawa Christian Hospital (JP), Ehime University Hospital (JP), Kitasato University Hospital (JP), Shimonoseki City Hospital (JP), Kameda Medical Center (JP), Chiba Cancer Center (JP), Sendai Medical Center (JP), Mie University Hospital (JP), Kyushu Hospital (JP), Okinawa Prefectural Chubu Hospital (JP), Kitakyushu Municipal Medical Center (JP), Mitsui Memorial Hospital (JP), Funabashi Municipal Medical Center (JP), Aichi Cancer Center (JP), Tokyo Women's Medical University (JP), Teine Keijinkai Hospital (JP), Hokkaido University Hospital (JP), Aso Iizuka Hospital (JP), Kyoto University Hospital (JP), Osaka International Cancer Institute (JP), Onomichi General Hospital (JP), Ehime University (JP), Urasoe General Hospital (JP), Sendai City Medical Center (JP), Institute of Gastroenterology, Tokyo Women's Medical University (JP), Aichi Cancer Center Hospital (JP), Kitasato University (JP), University of Yamanashi (JP), The University of Tokyo (JP), Wakayama University (JP), Kindai University (JP), Kumamoto University (JP), The University of Osaka (JP)
Good health and well-being
Pancreatic and Hepatic Oncology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon